Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
Status:
Terminated
Trial end date:
2021-01-21
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing
symptom severity when compared with placebo, in participants with Rett syndrome.